Physician
Wake Forest Pediatric Associates, PLLC
Wake Forest Pediatric Associates, PLLC was paid $9.93M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoWAKE FOREST PEDIATRIC ASSOCIATES, PLLC
WAKE FOREST, NC 27587
WAKE FOREST, NC 27587
33aNPI1790782126assigned 06/30/2005
33bProvider typePediatrics Physician
28Total paid$9.93M
24GClaims500,659
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#34 of 433
Median peer was paid$942K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,840 | $758K | |
| 2019 | 28,875 | $962K | |
| 2020 | 25,419 | $829K | |
| 2021 | 72,680 | $1.58M | |
| 2022 | 119,508 | $2.27M | |
| 2023 | 112,806 | $1.88M | |
| 2024incomplete | 115,531 | $1.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 49,056 | 42,789 | $3.04M |
| 99199 | Unlisted special service, procedure or report | 17% | 270,269 | 148,463 | $1.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 17,101 | 15,161 | $1.56M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 6,449 | 5,811 | $596K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5.8% | 29,067 | 26,432 | $580K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 5.4% | 14,106 | 12,778 | $538K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 4,767 | 4,237 | $405K |
| 0240U | 3.6% | 2,618 | 2,161 | $359K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.3% | 2,434 | 2,233 | $226K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.1% | 1,529 | 1,284 | $210K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 10,764 | 9,737 | $113K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,320 | 2,903 | $98K |
46 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,256 | $90K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,228 | $58K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,577 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,162 | $46K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 766 | $38K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 363 | $38K |
| D1206 | Topical application of fluoride varnish | <1% | 1,566 | $24K |
| 92551 | <1% | 13,421 | $17K | |
| 99173 | <1% | 16,781 | $17K | |
| 90474 | <1% | 848 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,249 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,472 | $14K |
| 99070 | <1% | 1,422 | $13K | |
| 90686 | <1% | 8,065 | $12K | |
| 99401 | <1% | 327 | $10K | |
| 0001A | <1% | 126 | $8K | |
| 0002A | <1% | 128 | $8K | |
| 96161 | <1% | 2,196 | $8K | |
| 94010 | <1% | 256 | $6K | |
| 0071A | <1% | 94 | $5K | |
| 0072A | <1% | 83 | $5K | |
| 83655 | <1% | 194 | $3K | |
| 94760 | <1% | 15,597 | $3K | |
| 36416 | <1% | 2,340 | $2K | |
| 80061 | Lipid panel | <1% | 132 | $2K |
| 96127 | <1% | 435 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 109 | $1K |
| 96160 | <1% | 294 | $998.58 | |
| 90651 | <1% | 76 | $910.48 | |
| 90734 | <1% | 59 | $868.86 | |
| 90620 | <1% | 16 | $826.24 | |
| 90716 | <1% | 202 | $278.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 76 | $180.28 |
| 90633 | <1% | 356 | $136.18 | |
| 90656 | <1% | 627 | $61.55 | |
| 90680 | 0% | 868 | $0.00 | |
| 90723 | 0% | 1,368 | $0.00 | |
| 99000 | 0% | 3,670 | $0.00 | |
| 90647 | 0% | 1,256 | $0.00 | |
| 91307 | 0% | 113 | $0.00 | |
| 90677 | 0% | 192 | $0.00 | |
| 87999 | 0% | 2,219 | $0.00 | |
| 90670 | 0% | 3,165 | $0.00 | |
| 90685 | 0% | 28 | $0.00 | |
| 90707 | 0% | 145 | $0.00 | |
| 91300 | 0% | 256 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEINSTEIN, NAOMI (MANAGER OF CORP)